Giuffrè G, Mormandi F, Barresi V, Bordi C, Tuccari G, Barresi G
Department of Human Pathology, Polyclinic Pad. D, University of Messina, Messina, Italy.
Eur J Histochem. 2006 Jan-Mar;50(1):45-50.
In order to assess if the quantity of silver-stained nucleolar organizer region (AgNOR) proteins represents a prognostic tool in gastric carcinoids, a standardised AgNOR analysis was performed on 24 samples collected from the pathology archives of the Universities of Messina and Parma; the samples were taken at surgery from 11 males and 13 females (mean age 55 yrs, age range 28-77 yrs); 13 cases were defined as Type I, 1 case as Type II and 10 cases as Type III; 16 cases showed a diameter <1 cm, 8 >1 cm. Only 6 tumours were deeply invasive, breaking through the muscularis propria or the subserosa. The proliferative status of carcinoids performed by Ki67 protein antibodies was available in 20/24 cases. The quantification of AgNORs was performed according to the guidelines of the Committee on AgNOR Quantification and the mean area (microm2) of AgNORs per nucleus (NORA) was determined by means of image analyser and specific software programs. The relationship between NORA values and Ki67 data was investigated by Spearman correlation test. The mean NORA value of all 24 gastric carcinoids was 1.279 microm2 (SD 0.404); values ranged from 0.734 to 2.142 microm2. A significantly higher (p < 0.001) mean NORA value (1.736 microm2; SD 0.283) was found in tumours larger than 1 cm, in comparison to the smaller neoplasms (1.051 microm2; SD 0.214); moreover, cases showing deep wall invasion exhibited a mean NORA value of 1.765 microm2 (SD 0.276), significantly higher (p < 0.001) than those with superficial growth (1.118 microm2; SD 0.296). Finally, a similar highly significant difference was seen between type III carcinoids (1.615 microm2; SD 0.375) and type I-II (1.040 microm2; SD 0.208). A linear relationship between Ki67 and corresponding NORA values was obtained by the Spearman correlation test (p = 0.001). No other significant correlations were found between mean NORA values and other clinico-pathological parameters. The AgNOR method seems to be an additional tool potentially able to predict the prognosis of this kind of endocrine tumour, facilitating the identification of fast-growing tumours and being able to directly correlate with the size, deep invasion of gastric wall and tumour type, generally considered as the best prognostic indicators.
为了评估银染核仁组织区(AgNOR)蛋白的数量是否可作为胃类癌的一种预后评估工具,我们对从墨西拿大学和帕尔马大学病理档案中收集的24份样本进行了标准化的AgNOR分析;这些样本取自11名男性和13名女性的手术标本(平均年龄55岁,年龄范围28 - 77岁);13例被定义为I型,1例为II型,10例为III型;16例肿瘤直径<1 cm,8例>1 cm。只有6例肿瘤有深度浸润,突破了固有肌层或浆膜下层。24例中有20例可获得通过Ki67蛋白抗体检测的类癌增殖状态。AgNOR的定量分析按照AgNOR定量委员会的指导原则进行,通过图像分析仪和特定软件程序确定每个细胞核的AgNOR平均面积(平方微米)(NORA)。通过Spearman相关性检验研究NORA值与Ki67数据之间的关系。24例胃类癌的平均NORA值为1.279平方微米(标准差0.404);值范围为0.734至2.142平方微米。与较小的肿瘤(1.051平方微米;标准差0.214)相比,直径大于1 cm的肿瘤的平均NORA值显著更高(p < 0.001)(1.736平方微米;标准差0.283);此外,显示有深壁浸润的病例的平均NORA值为1.765平方微米(标准差0.276),显著高于浅表生长的病例(1.118平方微米;标准差0.296)(p < 0.001)。最后,III型类癌(1.615平方微米;标准差0.375)与I - II型(1.040平方微米;标准差0.208)之间也存在类似的高度显著差异。通过Spearman相关性检验获得了Ki67与相应NORA值之间的线性关系(p = 0.001)。在平均NORA值与其他临床病理参数之间未发现其他显著相关性。AgNOR方法似乎是一种潜在的额外工具,能够预测这类内分泌肿瘤的预后,有助于识别生长迅速的肿瘤,并能够直接与肿瘤大小、胃壁深度浸润和肿瘤类型相关联,而这些通常被认为是最佳的预后指标。